Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-039807

Chief Executive Officer sold 24,190 shares at an average $17.01 ($411,512)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd Chief Executive Officer 2023-06-22 Sale 10b5-1 −2,978 $16.98 $50,558 1,622,488 D
Harris Todd Chief Executive Officer 2023-06-22 Sale 10b5-1 −500 $17.39 $8,693 1,621,988 D
Harris Todd Chief Executive Officer 2023-06-23 Sale 10b5-1 −14,231 $16.78 $238,798 1,607,757 D
Harris Todd Chief Executive Officer 2023-06-23 Sale 10b5-1 −6,481 $17.51 $113,464 1,601,276 D
Open-market sales · 24,190 sh · avg $17.01 · $411,512
Loading xslF345X04/doc4.xml…